Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.1.25 (
triphosphatase
)
1,529
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rho family guanosine
triphosphatase
(GTPase) 3 (
Rnd3
), a member of the small Rho GTPase family, is involved in the regulation of cell actin cytoskeleton dynamics, cell migration, and proliferation through the Rho kinase-dependent signaling pathway. We report a role of
Rnd3
in the pathogenesis of hydrocephalus disorder. Mice with
Rnd3
genetic deletion developed severe obstructive hydrocephalus with enlargement of the lateral and third ventricles, but not of the fourth ventricles. The cerebral aqueducts in
Rnd3
-null mice were partially or completely blocked by the overgrowth of ependymal epithelia. We examined the molecular mechanism contributing to this
Rnd3
-deficiency-mediated hydrocephalus and found that
Rnd3
is a regulator of Notch signaling.
Rnd3
deficiency, through either gene deletion or siRNA knockdown, resulted in a decrease in Notch intracellular domain (NICD) protein degradation. However, there was no correlated change in mRNA change, which in turn led to an increase in NICD protein levels. Immunoprecipitation analysis demonstrated that
Rnd3
and NICD physically interacted, and that down-regulation of
Rnd3
attenuated NICD protein ubiquitination. This eventually enhanced Notch signaling activity and promoted aberrant growth of aqueduct ependymal cells, resulting in aqueduct stenosis and the development of congenital hydrocephalus. Inhibition of Notch activity rescued the hydrocephalus disorder in the mutant animals.
...
PMID:Genetic deletion of Rnd3 results in aqueductal stenosis leading to hydrocephalus through up-regulation of Notch signaling. 2363 Feb 92
Rho family guanosine
triphosphatase
(GTPase) 3 (
Rnd3
), a member of the small Rho GTPase family, has been suggested to regulate cell actin cytoskeleton dynamics, cell migration, and apoptosis through the Rho kinase-dependent signaling pathway. The biological function of
Rnd3
in the heart is unknown. The downregulation of small GTPase
Rnd3
transcripts was found in patients with end-stage heart failure. The pathological significance of
Rnd3
loss in the transition to heart failure remains unexplored. To investigate the functional consequence of
Rnd3
downregulation and the associated molecular mechanism, we generated
Rnd3
(+/-) haploinsufficient mice to mimic the downregulation of
Rnd3
observed in the failing human heart.
Rnd3
(+/-) mice were viable; however, the mice developed heart failure after pressure overload by transverse aortic constriction (TAC). Remarkable apoptosis, increased caspase-3 activity, and elevated Rho kinase activity were detected in the
Rnd3
(+/-) haploinsufficient animal hearts. Pharmacological inhibition of Rho kinase by fasudil treatment partially improved
Rnd3
(+/-) mouse cardiac functions and attenuated myocardial apoptosis. To determine if Rho-associated coiled-coil kinase 1 (ROCK1) was responsible for
Rnd3
deficiency-mediated apoptotic cardiomyopathy, we established a double-knockout mouse line, the
Rnd3
haploinsufficient mice with ROCK1-null background (
Rnd3
(+/-/ROCK1-/-)). Again, genetic deletion of ROCK1 partially but not completely rescued
Rnd3
deficiency-mediated heart failure phenotype. These data suggest that downregulation of
Rnd3
correlates with cardiac loss of function as in heart failure patients. Animals with
Rnd3
haploinsufficiency are predisposed to hemodynamic stress. Hyperactivation of Rho kinase activity is responsible in part for the apoptotic cardiomyopathy development. Further investigation of ROCK1-independent mechanisms in
Rnd3
-mediated cardiac remodeling should be the focus for future study.
...
PMID:Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure. 2490 Oct 55